RP Bio Inc. (KOSDAQ:314140)
South Korea
· Delayed Price · Currency is KRW 6,250.00
+70.00 (1.13%)
At close: Apr 29, 2026
RP Bio Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 4,682 | -907.12 | 5,437 | 4,316 | 3,813 | Upgrade
|
| Depreciation & Amortization | 6,412 | 6,818 | 6,048 | 5,403 | 5,203 | Upgrade
|
| Loss (Gain) From Sale of Assets | 178.59 | 9.24 | - | -150.06 | 4.31 | Upgrade
|
| Loss (Gain) From Sale of Investments | -1.59 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | - | - | -5.77 | 10.54 | 14.57 | Upgrade
|
| Provision & Write-off of Bad Debts | 294.03 | 2.7 | 0.09 | -26.95 | -36.16 | Upgrade
|
| Other Operating Activities | 3,393 | 1,794 | 2,114 | 7,149 | 3,781 | Upgrade
|
| Change in Accounts Receivable | -1,135 | 2,334 | 777.83 | -1,651 | -4,355 | Upgrade
|
| Change in Inventory | -1,267 | 10,245 | 3,755 | -16,021 | -6,180 | Upgrade
|
| Change in Accounts Payable | 2,098 | -3,406 | -9,044 | 5,252 | 9,117 | Upgrade
|
| Change in Other Net Operating Assets | -2,179 | -3,366 | 1,498 | -3,125 | -1,902 | Upgrade
|
| Operating Cash Flow | 12,476 | 13,524 | 10,580 | 1,155 | 9,459 | Upgrade
|
| Operating Cash Flow Growth | -7.75% | 27.82% | 816.03% | -87.79% | 46.55% | Upgrade
|
| Capital Expenditures | -5,200 | -5,853 | -11,123 | -5,147 | -7,246 | Upgrade
|
| Sale of Property, Plant & Equipment | 19.58 | 14.38 | 69.73 | 165.55 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -411.27 | -157.78 | -41.02 | -132.18 | -24.59 | Upgrade
|
| Investment in Securities | -100 | 4,405 | -7,803 | -7.2 | 308.64 | Upgrade
|
| Other Investing Activities | -1,675 | 390.45 | -6.67 | -218.69 | -204.13 | Upgrade
|
| Investing Cash Flow | -7,066 | -1,501 | -18,264 | -5,939 | -7,166 | Upgrade
|
| Short-Term Debt Issued | 16,000 | 21,000 | - | 14,500 | 23,235 | Upgrade
|
| Total Debt Issued | 16,000 | 21,000 | - | 14,500 | 23,235 | Upgrade
|
| Short-Term Debt Repaid | -25,000 | -21,000 | -5,000 | -14,500 | -26,104 | Upgrade
|
| Long-Term Debt Repaid | -688.6 | -665.09 | -919.92 | -453 | -522.83 | Upgrade
|
| Total Debt Repaid | -25,689 | -21,665 | -5,920 | -14,953 | -26,627 | Upgrade
|
| Net Debt Issued (Repaid) | -9,689 | -665.09 | -5,920 | -453 | -3,392 | Upgrade
|
| Issuance of Common Stock | - | - | - | 16,287 | - | Upgrade
|
| Dividends Paid | - | -432.49 | - | - | - | Upgrade
|
| Other Financing Activities | - | - | -3.79 | -502.46 | - | Upgrade
|
| Financing Cash Flow | -9,689 | -1,098 | -5,924 | 15,332 | -3,392 | Upgrade
|
| Foreign Exchange Rate Adjustments | -6.61 | - | - | - | - | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | -0 | - | - | -0 | Upgrade
|
| Net Cash Flow | -4,285 | 10,925 | -13,608 | 10,547 | -1,099 | Upgrade
|
| Free Cash Flow | 7,276 | 7,670 | -543.31 | -3,992 | 2,213 | Upgrade
|
| Free Cash Flow Growth | -5.14% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 5.34% | 6.19% | -0.36% | -2.89% | 1.93% | Upgrade
|
| Free Cash Flow Per Share | 840.66 | 887.85 | -62.81 | -560.54 | 336.69 | Upgrade
|
| Cash Interest Paid | 831.79 | 1,316 | 1,816 | 989.75 | 638.38 | Upgrade
|
| Cash Income Tax Paid | 394.19 | 439.62 | 992.04 | 246.9 | 122.34 | Upgrade
|
| Levered Free Cash Flow | 5,302 | 6,556 | -6,112 | -3,592 | -1,246 | Upgrade
|
| Unlevered Free Cash Flow | 5,820 | 7,338 | -4,990 | -2,852 | -633.95 | Upgrade
|
| Change in Working Capital | -2,482 | 5,807 | -3,014 | -15,546 | -3,321 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.